United States Central Nervous System Drugs Market Report 2017

February 2017 | 106 pages | ID: U9976F83090EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Central Nervous System Drugs

Revenue, means the sales value of Central Nervous System Drugs

This report studies sales (consumption) of Central Nervous System Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Johnson & Johnson
• Pfizer
• Novartis
• Roche
• Sanofi-Aventis
• Merck
• GSK
• Bayer Schering
• Bristol-Myers Squibb
• AbbVie
• Eli Lilly
• AstraZeneca
• Takeda
• Actavis
• Teva
• Biogen
• Shire

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Central Nervous System Drugs in each application, can be divided into

• Application 1
• Application 2

Contents

United States Central Nervous System Drugs Market Report 2017

1 CENTRAL NERVOUS SYSTEM DRUGS OVERVIEW

1.1 Product Overview and Scope of Central Nervous System Drugs
1.2 Classification of Central Nervous System Drugs
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Central Nervous System Drugs
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Central Nervous System Drugs (2012-2022)
  1.4.1 United States Central Nervous System Drugs Sales and Growth Rate (2012-2022)
  1.4.2 United States Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES CENTRAL NERVOUS SYSTEM DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Central Nervous System Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Central Nervous System Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Central Nervous System Drugs Average Price by Manufactures (2015 and 2016)
2.4 Central Nervous System Drugs Market Competitive Situation and Trends
  2.4.1 Central Nervous System Drugs Market Concentration Rate
  2.4.2 Central Nervous System Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CENTRAL NERVOUS SYSTEM DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Central Nervous System Drugs Sales and Market Share by States (2012-2017)
3.2 United States Central Nervous System Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Central Nervous System Drugs Price by States (2012-2017)

4 UNITED STATES CENTRAL NERVOUS SYSTEM DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Central Nervous System Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Central Nervous System Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Central Nervous System Drugs Price by Type (2012-2017)
4.4 United States Central Nervous System Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CENTRAL NERVOUS SYSTEM DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Central Nervous System Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Central Nervous System Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CENTRAL NERVOUS SYSTEM DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Johnson & Johnson
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Central Nervous System Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Johnson & Johnson Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Central Nervous System Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.2 Central Nervous System Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Roche
  6.4.2 Central Nervous System Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Roche Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi-Aventis
  6.5.2 Central Nervous System Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi-Aventis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck
  6.6.2 Central Nervous System Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GSK
  6.7.2 Central Nervous System Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GSK Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer Schering
  6.8.2 Central Nervous System Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer Schering Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bristol-Myers Squibb
  6.9.2 Central Nervous System Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bristol-Myers Squibb Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AbbVie
  6.10.2 Central Nervous System Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AbbVie Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Eli Lilly
6.12 AstraZeneca
6.13 Takeda
6.14 Actavis
6.15 Teva
6.16 Biogen
6.17 Shire

7 CENTRAL NERVOUS SYSTEM DRUGS MANUFACTURING COST ANALYSIS

7.1 Central Nervous System Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Central Nervous System Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Central Nervous System Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CENTRAL NERVOUS SYSTEM DRUGS MARKET FORECAST (2017-2022)

11.1 United States Central Nervous System Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Central Nervous System Drugs Sales Forecast by Type (2017-2022)
11.3 United States Central Nervous System Drugs Sales Forecast by Application (2017-2022)
11.4 Central Nervous System Drugs Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Central Nervous System Drugs
Table Classification of Central Nervous System Drugs
Figure United States Sales Market Share of Central Nervous System Drugs by Type in 2015
Table Application of Central Nervous System Drugs
Figure United States Sales Market Share of Central Nervous System Drugs by Application in 2015
Figure United States Central Nervous System Drugs Sales and Growth Rate (2012-2022)
Figure United States Central Nervous System Drugs Revenue and Growth Rate (2012-2022)
Table United States Central Nervous System Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Central Nervous System Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Central Nervous System Drugs Sales Share by Manufacturers
Figure 2016 Central Nervous System Drugs Sales Share by Manufacturers
Table United States Central Nervous System Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Central Nervous System Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Central Nervous System Drugs Revenue Share by Manufacturers
Table 2016 United States Central Nervous System Drugs Revenue Share by Manufacturers
Table United States Market Central Nervous System Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Central Nervous System Drugs Average Price of Key Manufacturers in 2015
Figure Central Nervous System Drugs Market Share of Top 3 Manufacturers
Figure Central Nervous System Drugs Market Share of Top 5 Manufacturers
Table United States Central Nervous System Drugs Sales by States (2012-2017)
Table United States Central Nervous System Drugs Sales Share by States (2012-2017)
Figure United States Central Nervous System Drugs Sales Market Share by States in 2015
Table United States Central Nervous System Drugs Revenue and Market Share by States (2012-2017)
Table United States Central Nervous System Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Central Nervous System Drugs by States (2012-2017)
Table United States Central Nervous System Drugs Price by States (2012-2017)
Table United States Central Nervous System Drugs Sales by Type (2012-2017)
Table United States Central Nervous System Drugs Sales Share by Type (2012-2017)
Figure United States Central Nervous System Drugs Sales Market Share by Type in 2015
Table United States Central Nervous System Drugs Revenue and Market Share by Type (2012-2017)
Table United States Central Nervous System Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Central Nervous System Drugs by Type (2012-2017)
Table United States Central Nervous System Drugs Price by Type (2012-2017)
Figure United States Central Nervous System Drugs Sales Growth Rate by Type (2012-2017)
Table United States Central Nervous System Drugs Sales by Application (2012-2017)
Table United States Central Nervous System Drugs Sales Market Share by Application (2012-2017)
Figure United States Central Nervous System Drugs Sales Market Share by Application in 2015
Table United States Central Nervous System Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Central Nervous System Drugs Sales Growth Rate by Application (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Central Nervous System Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Central Nervous System Drugs Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Central Nervous System Drugs Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Central Nervous System Drugs Sales Market Share (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi-Aventis Central Nervous System Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Central Nervous System Drugs Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK Central Nervous System Drugs Sales Market Share (2012-2017)
Table Bayer Schering Basic Information List
Table Bayer Schering Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Schering Central Nervous System Drugs Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Central Nervous System Drugs Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Central Nervous System Drugs Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table AstraZeneca Basic Information List
Table Takeda Basic Information List
Table Actavis Basic Information List
Table Teva Basic Information List
Table Biogen Basic Information List
Table Shire Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Central Nervous System Drugs
Figure Manufacturing Process Analysis of Central Nervous System Drugs
Figure Central Nervous System Drugs Industrial Chain Analysis
Table Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015
Table Major Buyers of Central Nervous System Drugs
Table Distributors/Traders List
Figure United States Central Nervous System Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Central Nervous System Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Central Nervous System Drugs Production Forecast by Type (2017-2022)
Table United States Central Nervous System Drugs Consumption Forecast by Application (2017-2022)
Table United States Central Nervous System Drugs Sales Forecast by States (2017-2022)
Table United States Central Nervous System Drugs Sales Share Forecast by States (2017-2022)